Author Information
Kelvin Kai-wang To is a distinguished researcher affiliated with the State Key Laboratory for Emerging Infectious Diseases, Carol Yu's Centre for Infection and Division of Infectious Diseases at The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China. With extensive expertise in the field of infectious diseases, Kelvin To has made significant contributions to our understanding of various viral infections, particularly SARS-CoV-2, the virus responsible for COVID-19.Research Contributions
Kelvin To's research primarily focuses on the mechanisms of viral infections, vaccine responses, and the epidemiology of infectious diseases. In 2022, he contributed to a range of studies including the investigation of COVID-19 outbreaks, antibody responses to different vaccine platforms, and the antigenicity of SARS-CoV-2 variants. His work also extends to innovative diagnostic methods and the impact of viral infections on different organ systems, such as the testicular damage observed in animal models. Through these studies, Kelvin To has provided valuable insights into the behavior of SARS-CoV-2 and the effectiveness of vaccines, contributing to the global efforts in managing and mitigating the COVID-19 pandemic.Aliases
Throughout his academic career, Kelvin Kai-wang To has been referenced by various aliases, including Kelvin To, K. K. To, K. K.-w. To, Kelvin K.w. To, Kelvin K. To, Kelvin Kai-wong To, Kelvin Kai Wang To, Kelvin Kai–wang To, K. K. W. To, K To, Kelvin K W To, and Kelvin K. W. To. These variations reflect different ways his name has appeared in publications and collaborations.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
37,504 |
| h-index |
67 |
| Paper Count |
336 |
